Clinical Trial Update: Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606 [Phase 1]

View source ↗

Summary

Phase 1 single ascending dose study evaluating safety, tolerability, and pharmacokinetics of L606 has completed. The study targeted pulmonary arterial hypertens…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• L606

Snippet

Sponsor: Pharmosa Biopharm Inc. | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED